ArticleOrphanet journal of rare diseases2025
Open-label pilot study using hydroxytyrosol as dietary supplements in patients with mitochondrial diseases.
Tsz Sum Wong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it